Literature DB >> 30585108

De Novo Mutated TUBB2B Associated Pachygyria Diagnosed by Medical Exome Sequencing and Long-Range PCR.

Hui Wang1,2, Shaoyuan Li3, Shengli Li4, Niping Jiang2, Jimin Guo5, Wei Zhang3, Mei Zhong1, Jiansheng Xie2.   

Abstract

INTRODUCTION: A range of cerebrocortical development malformations (MCD) ranging from simplified gyral patterns to the complete loss of gyri and sulci is associated with mutations in a cluster of highly homolog β-tublin genes, such as TUBB2A and TUBB2B. CASE REPORT: The fetus had pachygyria, asymmetrical perisylvian polymicrogyria, dysplasia of the lateral sulcus and insula, agenesis of the splenium and partial agenesis of the body corpus callosum, cerebellar superior vermian hypoplasia with agenesis of the inferior vermis. Karyotype and microarray were normal. Trio Medical Exome Sequencing detected a de novo novel heterozygous mutation c.862G > A (p.E288K) in the tubulinpathy genes. Long-range PCR and Sanger sequencing specific for TUBB2A and TUBB2B gene detected a heterozygous variant c.862G > A specific to TUBB2B.
CONCLUSION: The combination of LR-PCR amplification and medical exome sequencing allows mutational assessment in tubulinopathy genes. Our study expands the spectrum of malformations associated with mutations in the β-tubulin gene TUBB2B.

Entities:  

Keywords:  Cortical development malformation; Medical exome sequencing; TUBB2B gene; long-rang PCR

Mesh:

Substances:

Year:  2018        PMID: 30585108     DOI: 10.1080/15513815.2018.1538273

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  2 in total

1.  Novel SPEG variant cause centronuclear myopathy in China.

Authors:  Jia Tang; Wei Ma; Yangran Chen; Runze Jiang; Qinlong Zeng; Jieliang Tan; Hongqing Jiang; Qing Li; Victor W Zhang; Jing Wang; Hui Tang; Liangping Luo
Journal:  J Clin Lab Anal       Date:  2019-10-18       Impact factor: 2.352

Review 2.  Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases.

Authors:  Antonella Sferra; Francesco Nicita; Enrico Bertini
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.